Regeneron Pharmaceuticals (REGN) Stock Price & Financial Analysis
Regeneron Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Regeneron Pharmaceuticals
What is the current stock price for REGN?
As of the latest trading session, REGN stock trades at $810.31. The 52-week range is $541.00–$859.34, with a day range of $799.42–$821.17.
What is the P/E ratio for REGN?
Regeneron Pharmaceuticals's trailing P/E ratio is 20.3, meaning investors pay $20.3 for every $1 of annual earnings. The forward P/E is 20.6, reflecting analyst expectations for future earnings. Regeneron Pharmaceuticals operates in the Healthcare sector.
Does REGN pay dividends?
Yes, Regeneron Pharmaceuticals pays a 0.46% annual dividend yield ($3.70 per share). The payout ratio is 9.2%. The last ex-dividend date was 2026-08-18.
What do analysts recommend for REGN?
Based on 18 analysts, the consensus for REGN is Buy.
What is the market cap of REGN?
Regeneron Pharmaceuticals's market capitalization is $85.89B, classifying it as a large-cap company. Regeneron Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.